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ABSTRACT 
 
 
Background and Objectives:  
Shivering is very unpleasant and stressful for the patient after 
undergoing a comfortable analgesic  surgery. It may induce arterial hypoxemia, 
lactic acidosis, increased intracranial pressure and intraocular pressure, 
interferes with haemodynamics and increase wound pain. Various 
pharmacological and non-pharmacological methods are available for control of 
shivering. Drugs like Clonidine, Doxapram, Pethidine, Tramadol etc have been 
tried but debate on an ideal antishivering drug still continues. Thus in a patient 
with limited myocardial oxygen reserve or known coronary artery disease, 
shivering may further compromise myocardial function. Here we are 
comparing a synthetic opioid, IV Tramadol at 1mg/kg with IV Pethidine 
0.5mg/kg, standard drug for treatment of shivering in quest for a more safe and 
efficacious drug. 
Materials and Methods:  
Seventy four patients who developed shivering after elective surgery 
under spinal anaesthesia were randomized into two groups each having thirty 
seven patients-tramadol group (Group 1) and pethidine group (Group 2). 
Patients were treated with 1mg/kg tramadol (Group 1) and 0.5mg/kg pethidine 
(Group 2). Haemodynamic stability, onset of action of each drug and side 
effects were closely monitored at different time intervals before shivering, 
during shivering and at 5 minute interval for 15 minutes. All patients were 
given spinal anaesthesia with 0.5% heavy bupivacaine. All the patients with 
shivering were administered oxygen at 6 L/min via venti mask. 
Statistical Analysis:  
Based on the ratio between recurrence of shivering with reference from 
study of Aditi.A Dhimer, with α error-5%, power-95%, sample size on each 
arm found to be 37 each, using EZR version 1.1 on R commander version 1.8-
4. 
Results: After intravenous administration of tramadol 1 mg/kg,cesation of 
shivering occured immediately. Shivering lasted for more time after 
administration of pethidine 0.5 mg/kg. Recurrence rate in tramadol group was 
found to be less than pethidine group. Nausea and vomiting was more in 
tramadol group. 
Conclusions: Intravenous tramadol is more effective than pethidine in 
controlling post spinal anaesthesia shivering.Tramadol has less response rate 
and recurrence.It is cheap as compared to pethidine and freely available 
without drug licence. 
Keywords: Tramadol, Pethidine, postoperative shivering, spinal anaesthesia  
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INTRODUCTION 
  Spinal anaesthesia is a popular and safe anaesthetic technique for 
various surgeries. Around 40-60% of the patients under spinal anaesthesia 
develop shivering. The incidence varies depending on the type of anaesthesia, 
gender, age, and the duration of the anaesthesia or the operation.  
Neutral temperature is defined as ambient temperature that results in 
least oxygen consumption. It varies according to age. It is 34◦C in preterm 
neonate, 32◦C in term neonate, 28◦C in adults. Critical temperature is that 
ambient temperature below which an unclothed, unanaesthetised person cannot 
maintain normal core body temperature. 
Shivering is described as an involuntary, oscillatory muscular activity. It 
is a physiological response of body to raise core temperature by increasing the 
metabolic heat production. It may be normal thermoregulatory shivering in 
response to body’s core hypothermia or may be a result of release of cytokines 
in response to surgical intervention. In a patient with shivering, oxygen 
consumption may increase by 200-500% along with rise in CO₂ production. In 
a patient with known coronary artery disease or limited myocardial oxygen 
reserve, shivering may affect the myocardial function. Shivering elevates 
intraocular pressure, intracerebral pressure and may increase wound pain. Even 
though shivering is not a life-threatening process, it can be a discomfort for the 
patient, and may interfere with  pulse oxygen saturation, electrocardiogram and 
blood pressure monitoring. 
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Tramadol is a synthetic opioid with moderate affinity for mu receptors 
and weak delta and kappa receptor affinity. It inhibit neuronal reuptake of 
norepinephrine and 5-HT. It has analgesic action with less chance of depression 
of ventilation. Studies1 have proved that intravenous tramadol in a dose of 1-2 
mg/kg is effective in post operative shivering. Tramadol2 has high safety 
profile and weak sedative properties. 
Pethidine is a synthetic opioid agonist at mu and kappa opioid receptors. 
It is a potent alpha₂ agonist, it might contribute to antishivering effects. It may 
produce analgesia postoperatively and during labour and delivery. Studies3 
have shown that role of  k opioid receptors are more significant than μ opioid 
receptors in the treatment of post anaesthetic shivering. 
In our study we are analysing the effect of  tramadol (1 mg/kg) and 
pethidine (0.5 mg/kg) intravenously for post spinal anaesthesia shivering.  
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AIMS AND OBJECTIVES: 
        
       1. To study the effect of Tramadol and Pethidine on post operative 
shivering. 
       2. To compare the efficacy and safety of Tramadol and Pethidine. 
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REVIEW OF LITERATURE 
HISTORY 
 James Leonard Corning(1855–1923), a neurologist in New York in the 
year 1885 administered first spinal analgesia. He was interested on work on 
cocaine on  spinal nerves of a dog. Accidentally, he injured the duramater. On 
October 12, 1885,  he injected 120 mg of cocaine at T11 and T12 interspace in 
a 45-year-old male patient and observed loss of sensation of the legs and 
perineum. He concluded that cocaine has action on spinal cord and proposed its 
spinal spasticity cases and for genitourinary surgeries. In 1891, Heinrich I 
Quincke(1842-1922)  realised that the dural sac which was described by 
Domenico Cotugno (1736-1822) in 1787, could be punctured by a needle 
insertion between lumbar spinous processes. Quincke tried to treat 
hydrocephalus by draining cerebrospinal fluid from dural sac but was 
unsuccessful. 
On August 15, 1898, August Bier and his assistant August Hildebrandt 
(1868-1854) used the Quincke method and injected 5-15 mg of cocaine to 
produce spinal anesthesia in 6 cases for surgeries on  lower part of the body. 
They also reported results of spinal anesthesia given to each other. It later 
became one of the classic clinical papers in medical literature. Arthur E. Barker 
(1850-1916) conducted studies to determine factors involved in spread of the 
local anesthetic within the subarachnoid space. He advised meticulous sterile 
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technique and introduced the use of dextrose to produce hyperbaric solutions. 
His conclusion on gravity as an essential determinant of spread of local 
anesthetic remains an important fact of the spinal technique today.   
The word opium is derived from opos, which means juice in Greek, as 
the drug is derived from juice of  opium poppy Papaver Somniferum. Opiates 
are drugs derived from opium and morphine, codeine, and thebaine are natural 
products. There are many semisynthetic congeners derived from them. 
 In 3rd century BC, Theophrastus has mentioned about opium in his 
writings . Many of the opium uses were appreciated from middle ages. In 1806, 
Serturner reported the isolation of a pure substance in opium which he named 
as morphine after Morpheus, the Greek god of dreams. By the middle of the 
nineteenth century, the use of pure alkaloids spread throughout the medical 
world. 
SHIVERING 
Shivering is commonly presented as an irregular tremor which on 
graphical evaluation seen as overlapping spikes of myofibril depolarization. It 
consist of  4 to 10 cycles per min, waxing-and-waning activity. This slow 
amplitude change occured simultaneously and synchronously in all muscle 
groups.4 Shivering is not usually seen  in pediatric age group . This is because, 
in paediatric patients, shivering threshold is low as compared to the 
vasoconstriction threshold,5shivering occurs as a last resort response to extreme 
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cold. In adults, sustained shivering increase metabolic heat production 50-100 
percent . This increase during shivering is small compared to that produced by 
exercise, which can increase metabolism 5 times, is ineffective. 
THERMOREGULATION DURING NEURAXIAL ANAESTHESIA 
  Epidural anaesthesia6,7 and spinal anaesthesia7,8each reduce the 
thresholds of shivering and vasoconstriction above the level of the block by 
about 0.6°C . This decrease cannot be explained by recirculation of neuraxially 
administered local anaesthetic because the effect is similar during both epidural 
and spinal anaesthesia6,7,8 even though the location and amount of  local 
anaesthetic administered differ. It is found that dose of intravenous lignocaine 
producing plasma concentrations  has no thermoregulatory effect.9  2-
chloroprocaine, a local anaesthetic with a plasma half-life of 20 seconds, also 
impairs thermoregulatory control when injected intrathecally.10,11 
The shivering thresholds and vasoconstriction  are decreased during 
regional anaesthesia,8 suggesting a change in central control. Intravenously or 
intramuscularly given local anesthesics may affect centrally mediated 
thermoregulation  by modulating afferent thermal input from lower limbs. The 
basis behind this is that tonic cold signals dominate thermal signals in a 
operating room environment.12 Regional anesthesia blocks all thermal input 
from the blocked areas, which is primarily cold information. The brain may 
then interpret reduced cold information as relative leg warming. This is 
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considered as an unconscious process in which perceived temperature does not 
increase.13As skin temperature is an important input to thermoregulatory 
control system, leg warming proportionately reduce the  possibility of 
vasoconstriction and  decrease shivering thresholds. Consistent with this 
theory, a skin temperature of leg near 38°C is required to produce the same 
reduction in cold-response thresholds in an unanesthetized patient as produced 
by regional anesthesia.14 In addition to this, decrease in thresholds vary 
depending on the number of spinal segments blocked.15 Thus major conduction 
anesthesia may decrease the shivering and vasoconstriction thresholds by 
producing an abnormal increase in apparent leg temperature. However, this 
explanation remains speculative.  
As neuraxial anesthesia prevents shivering and vasoconstriction in 
blocked regions, epidural anesthesia reduce the maximum shivering intensity. 
Epidural anesthesia also decrease the gain of shivering, which imply that the 
regulatory system is not able to compensate for paralysis of lower body.16  
Usually neuraxial anesthesia is supplemented with analgesic and 
sedative medications which can impair thermoregulatory control17,18,19 The 
impairment become severe with combination of patient comorbidities, old age, 
analgesics and sedatives and neuraxial blockade. 
Core hypothermia during regional anesthesia may not trigger cold 
perception .6,20 It is because, thermal perception is mainly determined by skin 
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than core temperature. Core hypothermia is followed by a real elevation in skin 
temperature during regional anesthesia. The end result is, continued or more 
warmth perception with activation of autonomic thermoregulatory responses 
including shivering . 6,20  
Altogether, these data imply that various aspects of thermoregulatory 
control are inhibited by neuraxial anaesthesia. The shivering and 
vasoconstriction thresholds are decreased by regional techniques6,7,8,14,15 and 
which is further reduced by advanced age22 and adjuvant drugs.18,21 Even if 
once triggered, the maximum response and gain intensity of shivering are about 
half the normal. Thus behavioral thermoregulation is impaired.20  During 
regional anesthesia cold defenses are triggered at a lower temperature and once 
stimulated defenses are less effective, and patients often do not recognize 
hypothermia. As core temperature are not monitored during regional 
anesthesia, substantial hypothermia remains undetected in most of the 
patients.23 
Opioid-based anesthesia probably reduces thermoregulatory thresholds 
to a similar extent as that of  potent inhaled agents .18 However, pethidine 
stands unique among opioids in its ability to effectively attenuate or terminate 
shivering. The antishivering effect of pethidine is primarily related to reduction 
in the shivering threshold 24 and seems to be mediated by its activity on the κ-
receptor.25But, more specific κ-receptor agonist nalbuphine do not exhibit 
significant antishivering activity.26 Pethidine exerts agonist activity at the α2B-
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adrenoreceptor subtype, this may be the possible reason for its antishivering 
action .27 Alfentanil, morphine, and fentanyl are not as effective as pethidine in 
the treatment of postoperative shivering. Tramadol (0.5 mg/kg) suppressed 
post–epidural anesthetic shivering in parturients as effectively as pethidine 
(0.5 mg/kg),28 but the incidence of somnolence was less with tramadol 
compared to pethidine.11 
Shivering during neuraxial anaesthesia 
Shivering is common response during neuraxial anesthesia.Four causes 
have been postulated for shivering:  
1) shivering can occur as a response reaction to low body temperature,                       
2) shivering can occur in patients with normal temperature and those having 
fever ;  
3) intrathecal or epidural administration of local anaesthetics can stimulate cold 
receptors; and,                 
4) non-thermoregulatory shivering .              
There can be other causes for shivering. For example, a cause for the 
intense shivering in caesarean patients occuring immediately after spinal or 
epidural anesthesia, i.e even before core temperature had time to reduce, is still 
unknown. 
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Most shivering associated with neuraxial anaesthesia appears to be 
normal shivering occuring as a response to hypothermia. Shivering is  preceded 
by vasoconstriction and core hypothermia atleast in volunteers receiving 
neuraxial anaesthesia.6 Electromyographic evaluation can confirm diagnosis of 
shivering by their typical pattern.29   Fever during surgery considered as a rare 
etiology of shivering. 
All birds and mammals have spinal thermoreceptors. There is a chance 
for development of shivering in patients receiving cold drugs neuraxially . This 
was proved by a study on pregnant patients.Those patients who received cold 
solutions intrathecally had more shivering rate compared to those who received 
warm solutions.30  In contrast, study on normal patients32 did not show 
increased incidence of shivering even after large amount of cold saline 
injection epidurally.31 This summarize that temperature of local anaesthetic 
injected rarely stimulates shivering. 
  All shivering-like tremor are not thermoregulatory. Mild shivering is 
noted in patients during surgery33 or during labor34 . This may be due to 
sympathetic nervous system activation35 or due to pain. Exact cause is 
unknown. 
It is a serious complication that 100 % increase in oxygen consumption 
in proportion to intraoperative heat loss.36 As oxygen demand is increased, 
myocardial ischaemia  can occur in patients with compromised myocardial 
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function. In addition to increasing intracranial pressure and intraocular 
pressure, postoperative shivering possibly elevate wound pain by stretching 
sutures. Most important determinants of shivering risk found are young age and 
low core temperature.37 
Treatment of postanaesthetic shivering  
  Skin surface warming, warming room can reduce shivering as skin 
temperature has a role in temperature regulation .38 Skin surface has 20% 39,40 
and the lower part of body has 10% contribution in temperature regulation14. In 
short, skin warming is beneficial for only a small fraction of patients. 
Heat loss by conduction is reduced by warming the room and heat lost 
by convention is minimised by warm blankets. In infants, use of double shelled 
isolette during transport decrease heat lost by radiation and use of plastic 
wrap,humidification of inspired air lessen heat lost by evaporation. 
  Postanesthetic shivering can also be treated with many drugs, including 
physostigmine (0.04 mg/kg IV),43  clonidine (75 µg IV),41  tramadol,42  
ketanserin (10 mg IV), 41 magnesium sulfate (30 mg/kg IV)45  , 
dexmedetomidine, and nefopam (0.15 mg/kg)44 . The specific mechanisms by 
which ketanserin, tramadol, physostigmine, and magnesium sulfate stop 
shivering remain unknown. Clonidine46 and dexmedetomidine47 reduce the 
shivering and vasoconstriction thresholds, thus suggesting that they act on the 
central thermoregulatory system and not preventing shivering peripherally.  
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Alfentanil, a pure µ-receptor agonist, significantly alters 
thermoregulatory control.18 Pethidine is more effective in treating shivering 
than other µ-agonists.48 It is found that it reduces shivering threshold two times 
as much as the vasoconstriction threshold19 without reducing gain or maximum 
intensity of shivering.24 The efficacy of pethidine is partially preserved during 
naloxone administration at a dose of 0.5 µg/kg/min but virtually obliterated by 
large doses (5.0 µg/kg/min).25 These data imply about the action of this drug on 
non–µ-opioid receptors. Pethidine possesses considerable κ activity49 and  has 
central anticholinergic activity. Neither of these mechanism mediate pethidine's 
special antishivering activity.  
SPINAL ANAESTHESIA 
Spinal anaesthesia is also called spinal analgesic or spinal block or  
subarachnoid block(SAB). It is a form of regional anaesthesia in which local 
anaesthetic is injected  into subarachnoid space through a fine needle, usually 
9 cm long (3.5 inches). Longer needles of 12.7 cm / 5 inches are available for 
extremely obese patients. Spinal needle has a point or small bevel at the tip. 
Pencil point needles are also available. 
  Spinal, epidural, and caudal neuraxial blocks result in sympathetic 
block, sensory analgesia or anaesthesia and motor blockade, depending on the 
dose, concentration, or volume of local anesthetic injected after insertion of a 
needle in the plane of the neuraxis.  
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ANATOMY 
 The spine consist of  vertebral bones and fibrocartilaginous 
intervertebral disc. There are seven cervical, twelve thoracic, and five lumbar 
vertebra. 5 sacral vertebrae fused to form sacrum, and small rudimentary 
coccygeal vertebra are also present. The spine provides protection for the spinal 
cord and nerves, structural support for the body, and allows a degree of 
mobility. Paired spinal nerves exit at each vertebral level. 
Size and shape of vertebra at various level differs. The atlas, the first 
cervical vertebra, lacks a body and has unique articulations with the base of the 
skull and the second vertebra. The axis, second vertebra, has atypical 
articulating surfaces. All thoracic vertebrae articulate with their corresponding 
rib. 
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                                  Figure 2 :Figure of vertebra 
The part between the spinous processes and the transverse processes is 
called lamina and the part between the transverse processes and the vertebral 
body is called pedicle.  The hollow rings become the spinal canal in which the 
spinal cord and its coverings pass. The individual vertebral bodies are 
connected by the intervertebral disc.Each vertebra has 4 small synovial joints, 2 
joints articulate with above vertebra and 2 joints articulate with the vertebra 
below it. These are the facet joints near the transverse processes. The pedicles 
are notched superiorly and inferiorly, these notches form the intervertebral 
foramina, through which the spinal nerves exit.5 Sacral vertebrae fuse to one 
large bone, the sacrum, but each one has discrete anterior and posterior 
intervertebral foramina. The laminae of fifth sacral vertebra and  fourth sacral 
vertebra do not fuse completely, leaving a caudal opening to the spinal canal, 
called the sacral hiatus .  
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The spinal column forms a double C, being convex anteriorly in the 
cervical and lumbar regions. Ligaments provide structural support and together 
with supporting muscles, maintain the unique shape of spine. Anteriorly, the 
vertebral bodies and intervertebral disc are connected and supported by the 
anterior and posterior longitudinal ligaments. Posteriorly, the ligamentum 
flavum, interspinous ligament, and supraspinous ligament provide additional 
stability. Using the midline approach, a needle passes through these 3 posterior 
ligaments and through an oval space between the bony lamina and spinous 
processes of adjacent vertebra. 
The Spinal Cord 
The spinal canal contains, spinal cord with its coverings called  
meninges, fatty tissue, and a venous plexus. Meninges have three layers: the 
pia mater, the arachnoid mater, and the dura mater; all are continuous with their 
cranial counterparts. The pia mater is closely adherent to spinal cord, whereas 
the arachnoid mater is usually closely adherent to thicker and denser dura 
mater. Cerebrospinal fluid (CSF) is contained between the pia and arachnoid 
mater in the subarachnoid space. The spinal subdural space is poorly 
demarcated. It exists between the dura and arachnoid membranes. The epidural 
space is a better defined potential space within the spinal canal that is bounded 
by the dura and the ligamentum flavum. 
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                                       Figure 3:Spinal cord 
In adults,spinal cord extends from foramen magnum to the lower border 
of L1. In infants, the spinal cord ends at L3 and moves up as they grow old. 
The anterior and posterior nerve roots at each spinal level join together and exit 
through intervertebral foramina as spinal nerves from C1 to S5. At the cervical 
level, the nerves pass above their respective vertebrae, but from T1 they exit 
below respective vertebrae. There are 8 cervical nerve roots but only 7 cervical 
vertebrae. The cervical and upper thoracic nerve roots join together from the 
spinal cord and exit through vertebral foramina nearly at the same level. As the 
spinal cord normally ends at L1, lower nerve roots course some distance before 
exiting intervertebral foramina. These lower spinal nerves form the cauda 
equina ( horse's tail ). Therefore,  lumbar  or subarachnoid puncture done below 
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L1 in an adult  and L3 in a child avoids potential needle injury to the cord. 
Cauda equina injury, rarely occurs. As these nerve fibres are floating in CSF, 
there will just slip off during spinal needle insertion rather than getting injured.  
The dural sac and the subarachnoid and subdural spaces usually extend 
to S2 in adults and often to S3 in case of children. Because of this fact and the 
smaller body size, caudal anesthesia carries a greater risk of subarachnoid 
injection in children than in adults. Filum terminale is an extension of piamater. 
It penetrates the duramater and attaches conus medullaris to the periostium of 
the coccyx .  
The blood supply to the spinal cord and nerve roots is provided by a 
single anterior spinal artery and paired posterior spinal arteries. The anterior 
spinal artery originate from the vertebral artery at the base of the skull and 
course down along the anteriorly. The anterior spinal artery supplies the 
anterior ⅔ of the cord, whereas the 2 posterior spinal arteries supply the 
posterior ⅓. The posterior spinal arteries origin from the posterior inferior 
cerebellar arteries and course down along the posterior surface of the cord 
medial to the dorsal nerve roots. The anterior and posterior spinal arteries 
receive additional blood flow from the intercostal arteries in the thorax and the 
lumbar arteries in the abdomen. One of these radicular arteries is typically 
large, the artery of Adamkiewicz, or arteria radicularis magna, arise from the 
aorta . It is unilateral and always arises on the left side, providing the major 
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blood supply to the anterior, lower two-thirds of the spinal cord. Injury to this 
artery can result in anterior spinal artery syndrome.50  
 
                              Figure 4:Blood supply to spinal cord 
Cerebrospinal Fluid 
CSF is found in the cerebral ventricles and cisterns and in the 
subarachnoid space surrounding the brain and spinal cord. Its predominant 
function is to protect the CNS against injury. 
  CSF is mostly formed by the choroid plexuses of the cerebral (mainly 
lateral) ventricles. Some amounts are formed directly by the ventricle’s 
ependymal cell linings and some amount from fluid leaking into the 
perivascular spaces surrounding cerebral vessels (blood–brain barrier leakage). 
In elderly, normal total CSF production is about 21 ml/h (500 ml/d), total CSF 
volume is only about 150 ml. CSF flows from the lateral ventricles through the 
intraventricular foramina (foramen of Monro) and then into the third ventricle 
through the cerebral aqueduct or aqueduct of Sylvius into the fourth ventricle, 
and through the median aperture of the fourth ventricle (foramen of Magendie) 
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and the lateral aperture of the fourth ventricle (foramina of Luschka)  drain into 
the cerebellomedullary cistern (cisterna magna). CSF from the 
cerebellomedullary cistern, enters the subarachnoid space, circulating around 
the brain and spinal cord before being absorbed in arachnoid granulations over 
the cerebral hemispheres. 
  Formation of CSF involves secretion of sodium in the choroid plexuses. 
The resulting fluid is isotonic with plasma despite reduced potassium, 
bicarbonate, and glucose concentrations. Its protein content is very less. 
Carbonic anhydrase antagonist like acetazolamide, corticosteroids, 
spironolactone, isoflurane, furosemide, and vasoconstrictors reduce CSF 
production. 
Translocation of fluid from the arachnoid granulation into cerebral 
venous sinuses involves absorption of CSF. Some amounts are absorbed at 
nerve root sleeves and by meningeal lymphatics. Although the mechanism 
remains unclear, absorption is inversely proportionate to cerebral venous 
pressure and directly proportionate to intracranial pressure. As the spinal cord 
and brain lack lymphatics, absorption of CSF is the important source by which 
perivascular and interstitial protein is returned to blood.50 
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Physiological effects of neuraxial blockade 
Somatic blockade 
When there is sensory blockade, it interrupts both visceral and somatic 
painful stimuli, motor blockade produce relaxation of skeletal muscle. The 
effect of local anaesthetics on nerve fibers differs and depend on the size of 
nerve fiber, whether it is myelinated, and the concentration obtained and the 
extent of contact . Spinal nerve roots contain different types of  fiber. Smaller 
and myelinated fibers are mostly more easily blocked than larger and 
unmyelinated ones. The differential blockade typically it results in sympathetic 
blockade which can be evaluated by temperature sensitivity;  sensory block 
(pain, light touch) at two segment lower level; and the motor blockade, two 
segments lower than sensory blockade.  
Autonomic Blockade 
Neuraxial blockade produce both sympathetic and some 
parasympathetic blockade . Sympathetic transmission from the spinal cord may 
be explained as thoracolumbar, whereas parasympathetic outflow is 
craniosacral. Sympathetic preganglionic nerve fibers are small, myelinated B 
fibers.They leave out of spinal cord with the spinal nerves from T1 -L2 level 
and may course many levels above or down the sympathetic chain before they 
join with a postganglionic cell in a sympathetic ganglia. Parasympathetic 
preganglionic fibers comes out of the spinal cord along with the cranial and 
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sacral nerves. Vagus nerve not blocked in neuraxial blockade. The 
physiological responses brought about by neuraxial blockade is due to reduced 
sympathetic tone and unopposed parasympathetic tone. 
Cardiovascular Manifestations  
Neuraxial blocks produce reduction in blood pressure and that may be 
followed by a reduction in heart rate and cardiac contractility. It depend on the 
level of sympathetic blockade. Sympathetic fibers arising from T5 - L1, 
innervating venous and arterial smooth muscle, regulate the vascular tone. So 
sympathetic blockade cause vasodilation of the venous system, pooling of 
blood, and thus reduced venous return to the heart. Arterial vasodilation may 
also reduce systemic vascular resistance but it will be compensated by 
vasoconstriction above the blockade level. A high block can affect cardiac 
accelerator fibers arising from T1–T4 inaddition to inhibition of 
vasoconstriction. As a result, hypotension, decreased contractility and 
bradycardia occurs. These effects worsen in pregnancy or head up posture due 
to reduction in venous return. The sudden cardiac arrest seen with spinal 
anesthesia may be explained by unopposed vagal tone. 
Anticipate deleterious cardiovascular effects and prepare with necessary 
steps to reduce the degree of hypotension.In a healthy adult, hypotension can 
be prevented to an extent by fluid loading with 10–20 ml/kg of intravenous 
fluid. Hypotension if occurs, can be managed with changing position to head 
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low , increasing rate of fluid infusion and vassopressor. Atropine can be used 
for treatment of symptomatic reduction in heart rate. Phenylephrine, which is 
an alpha agonist, can be used to treat hypotension. Ephedrine, alpha agonist, 
enhance contractility and rise heart rate directly and produce vasoconstriction 
indirectly. If severe bradycardia, hypotension persist despite these measures, 
epinephrine (5–10 mcg intravenously) should be administered immediately. 
Pulmonary Manifestations 
Clinically changes in pulmonary physiology are usually minimal with 
neuraxial blocks because innervation of diaphragm is by the phrenic nerve with 
fibers originating from C3–C5. Even with high thoracic levels, tidal volume 
remain unchanged; there is only a small decrease in vital capacity, which 
results from loss of the abdominal muscle’s contribution to forced expiration. 
Phrenic nerve function may remain even in cases of total spinal anesthesia. 
Apnea often resolves with hemodynamic resuscitation, suggesting that brain 
stem hypoperfusion is responsible for apnea.  
Severe chronic lung disease patients may rely upon accessory muscles 
of respiration like intercostal and abdominal muscles to actively inspire or 
exhale. High block affect these muscles. For these reasons, neuraxial blocks 
should be used cautiously in patients with limited respiratory reserve. Thoracic 
or upper abdominal surgery is associated with reduced diaphragmatic function 
postoperatively (from decreased phrenic nerve activity) and reduced functional 
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residual capacity (FRC), which can ultimately lead to atelectasis and hypoxia 
via ventilation/perfusion mismatch.   
Gastrointestinal Manifestations 
Sympathetic supply for gastrointestinal system is from T5 to L1 level. 
Blockade at this level result in small, contracted gut and increase peristalsis. 
Hepatic blood flow will reduce with decrease in mean arterial pressure 
from any anesthetic technique. For intraabdominal surgery, the decrease in 
hepatic blood flow is related more to surgical manipulation than to anesthetic 
technique . 
Urinary Tract Manifestations 
Autoregulation maintain renal blood flow, and there is little clinical 
effect upon renal function from neuraxial blockade. Neuraxial blockade at 
lumbar and sacral level, affect parasympathetic and sympathetic bladder 
function. Loss of autonomic bladder control results in urinary retention. If no 
urinary catheter is anticipated perioperatively, it is wise to use the shortest 
acting and smallest amount of drug required for the surgical procedure and if 
possible, limit the amount of intravenous fluid administration. The patient 
should be monitored for urinary retention to avoid bladder distention following 
neuraxial anesthesia. 
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Metabolic & Endocrine Manifestations 
Surgical trauma produces a neuroendocrine response through a localized 
inflammatory response and activation of visceral and somatic afferent nerve 
fibers. This result in elevation in levels of norepinephrine, adrenocorticotropic 
hormone, epinephrine, vasopressin and cortisol. It stimulate renin angiotensin 
aldosterone axis. Clinical manifestations include tachycardia, intraoperative 
and postoperative hypertension, protein catabolism, hyperglycemia, altered 
renal function and suppressed immune responses. Blockade can partially block 
(during major invasive surgery) or totally suppress (during lower extremity 
surgery) this stress response. By decreasing catecholamine release, neuraxial 
blocks may reduce perioperative arrhythmias and reduce the incidence of 
ischemia. Neuraxial block should precede incision and extend into the 
postoperative period to achieve maximum blunting of neuroendocrine stress 
response.  
Indications of spinal anaesthesia 
Lower extremity surgery 
Lower abdominal surgery,                                    
Urogenital surgery  
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Inguinal surgery and                                                                                               
Rectal surgery.            
 
                                                                                                                        
Contraindications of spinal anaesthesia 
Patient refusal,                                                                                                        
Infection at the site of injection,                                                                             
Severe hypovolemia,                                                                                               
Bleeding diathesis,                                                                                                  
Elevated intracranial pressure,                                                                               
Anatomical disorders of the spine and                                                                    
Severe stenotic valvular heart disease or ventricular outflow obstruction             
 Spinal Anesthetic Agents 
            Many local anesthetics were used for spinal anesthesia in the past, but
now only a few are in use. Only preservative-free local anaesthetic solutions 
are used now. Adding vasoconstrictors (α-adrenergic agonists) and opioids may 
enhance the quality and prolong the duration of spinal anaesthesia . 
Vasoconstrictors include phenylephrine (1–2 mg) and epinephrine (0.1–0.2 
mg). Both these drugs decrease the uptake and clearance of local anesthetics
from CSF and may have weak spinal analgesic properties.  
          Heavy bupivacaine and tetracaine are the most commonly used drugs for 
spinal anesthesia. Both these drugs are slow in onset of action (5 to10 min) and 
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have long duration of action (90 to120 min). Tetracaine has more motor 
blockade than bupivacaine in same dose. Addition of adrenaline to spinal 
bupivacaine do not have much change in duration of action. But adrenaline
used in combination with tetracaine has prolonged duration of action. 
Phenylephrine prolongs tetracaine anaesthesia but has no effect on bupivacaine 
spinal blocks. Lignocaine and procaine have a fast onset of action (3–5 min) 
and short duration of action (60–90 min).Although lignocaine for spinal 
anesthesia has been used worldwide, there are reports of phenomenon of cauda 
equina syndrome and transient neurological symptoms (TNS).  
               Hyperbaric spinal anesthesia is more commonly used than the isobaric 
or hypobaric techniques. The level of anesthesia is  dependent on the patient's 
position during and immediately after injection. In the sitting position, saddle 
block can be achieved by making the patient sit for 3 to 5 min after injection. If 
the patient is changed from sitting position to supine immediately after 
injection, the agent will move more cephalad to the dependent region defined
by the thoracolumbar curve,as drug not fully fixed. Hyperbaric anesthetics
injected intrathecally with the patient in a lateral decubitus position are used for 
unilateral lower extremity procedures. The patient is placed laterally with the
extremity to be operated on in  dependent position. If the patient is kept in this
position for about 5 min following drug administration, the block will  be 
denser and achieve a higher level on the operative dependent side.  
             If  hypobaric spinal anaesthesia is chosen for surgical procedures 
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involving hip or lower extremity fracture, patient need not lie on the fractured 
extremity. 
               Regardless of the anaesthetic agent used, the expected effect is to 
block the transmission of afferent nerve signals from peripheral nociceptors. 
Produce analgesia as sensory signals from the site are blocked. The extent of 
blockade produced depends on concentration and amount of local anaesthetic 
used and the properties of the axon. Thin unmyelinated C-fibres which are 
associated with pain and heavily myelinated, small preganglionic sympathetic 
are blocked first, and thick, heavily myelinated A-alpha motor neurons are 
moderately blocked. Pressure sensation may still persist after neuraxial 
blockade due to incomplete blockade of the thicker A-beta mechanoreceptors. 
COMPLICATIONS OF SPINAL ANAESTHESIA 
• Post dural puncture headache (PDPH)  –related with the type and size of  
           spinal needle used. 
• Hypotension  
• Cauda equina injury - due to high insertion site. 
• Cardiac arrest - very rare. It is due to the underlying comorbidities of the 
            patient. 
• Spinal canal haematoma with or without any neurological symptoms can 
occur due to compression over spinal nerves.  CT/MRI confirms the diagnosis. 
It should be treated immediately by surgical decompression. 
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elimination half-life noted in elderly patients; but in neonates and infants, the 
median elimination half-life prolonged; i.e 8 to 10 hours, with greater 
individual variability which is more compared to adults. 
80 to 100 mg intramuscular dose of  pethidine is equivalent to about 10 mg of 
intramuscular morphine.  Pethidine produces sedation, euphoria, nausea, 
vomiting, and depression of ventilation as morphine in same analgesic dose of 
morphine. Pethidine is well absorbed from the gastrointestinal tract. 
 
Metabolism  
First-pass uptake of meperidine by lungs is about 65%. It has high 
clearance rate (10 ml/kg/min) which reflects high hepatic extraction ratio; its 
N-demethylation in liver form normeperidine which is the principal metabolite, 
and it is then hydrolyzed to meperidinic acid. Both metabolites are conjugated53 
and excreted through kidneys. Normeperidine is pharmacologically active 
metabolite and  is potentially toxic. 
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produces analgesia.54 This has led to its popularity for epidural and 
subarachnoid administration, especially in obstetric anesthesia. Neuraxial 
pethidine have found to produce motor, sensory blockade and sympatholytic 
effects that are not exhibited by other opioids. These effects are due to local 
anaesthetic effects. Pethidine is found to be effective in treating postoperative 
shivering that can result in increases in oxygen demand. 
 Pethidine in treatment of shivering 
  Pethidine is effective in reducing shivering due to different causes, 
including fever, general and epidural anesthesia, administration of 
amphotericin B, hypothermia and transfusion reactions. It eliminates visible 
shivering and thus side effects of shivering55 following epidural and general 
anesthesia. Antishivering effect of pethidine is not due to their action on µ-
opioid receptors as other opioids like morphine or fentanyl do not exhibit this 
effect. So  this effect is considered to be mediated by κ-opioid receptors. Low 
doses of naloxone (which block µ receptors), did not reverse the antishivering 
effect of pethidine, but high-dose of naloxone, which block both κ and µ 
receptors reverse the antishivering effect.25 The observation that other types of 
drugs, such as serotonin antagonists,41 α1-adrenergic agonists (clonidine 1.5 
µg/kg), and propofol,17 can reduce postoperative shivering suggests that a 
nonopioid mechanism is also involved. Physostigmine 0.04 mg/kg can also 
prevent postoperative shivering, suggesting a role for the cholinergic system.43                        
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Side Effects 
Pethidine has similar side effects as that of morphine. It causes rise in 
heart rate due to atropine-like action.  Orthostatic hypotension may be due to its 
interference with compensatory sympathetic nervous system reflexes. It 
decreases myocardial contractility in large doses and this effect cannot be 
reversed with naloxone.56 1 mg/kg in patients with cardiac disease decrease 
cardiac index, heart rate, and rate–pressure product.57  In high doses, pethidine 
causes significantly more hemodynamic instability than fentanyl or morphine 
and its derivatives,58 this effect at least partially contributed by histamine 
release. In a comparison study of opioids used for balanced anesthesia, Flacke 
et al.58 found that 25% patients in pethidine group had abnormally elevated 
plasma histamine concentrations and experienced severe hypotension. 
Interestingly, only 1 patient in morphine group  had  similar histamine plasma 
concentration(morphine dose used was 0.6mg/kg) . So in short, pethidine is not 
recommended in high doses for  safe clinical anaesthesia. 
  Norpethidine, an active metabolite, stimulate central nervous system and 
cause seizures and delirium. It cross the placenta and impairs ventilation.  It 
cause mydriasis due to modest atropine-like actions. 
Active Metabolites 
Normeperidine is an active metabolite with action on central nervous 
system. Mood alterations such as restlessness and apprehension, as well as 
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neurotoxic effects such as myoclonus, tremors and seizures, have been 
reported. The elimination half-life of  norpethidine is 14 - 21 hours, this is 
longer than the parent compound, and therefore it gets accumulated with 
prolonged or  repeated administration, especially in patients with renal 
impairment.58 Seizures and myoclonus are reported in those receiving pethidine 
for a longer period. Patients who developed seizures had  mean plasma 
normeperidine concentration of 0.81 µg/mL.59 Pethidine dose of 1000mg/day is 
associated with an increased risk of seizures, even in patients without renal 
dysfunction. 
Dosage and Administration of Pethidine 
Single dose of pethidine has shorter duration of action compared to 
morphine. Intravenous analgesic doses of meperidine for adults is 0.1 to 1 
mg/kg. Intravenous doses for shivering is 12.5 to 50 mg IV. High dose of this 
drug are not recommended because of hemodynamic instability.  Repeated 
dose or high single dose or prolonged administration may produce seizures 
because of its active metabolite norpethidine and the total daily dose should not 
exceed 1,000 mg in 24 hours.60 
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Synthesis and stereoisomerism 
  Tramadol 2-(dimethylaminomethyl)-1-(3-methoxyphenyl)cyclohexanol] 
has two stereogenic centers at cyclohexane ring.  2-(dimethylaminomethyl)-1-
(3-methoxyphenyl)cyclohexanol may exist in 4 different forms: 
• (1R,2R)-isomer 
• (1R,2S)-isomer 
• (1S,2S)-isomer 
•  (1S,2R)-isomer 
The synthetic pathway leads to 1:1 mixture of (1S,2S)-isomer and 
(1R,2R)-isomer as  main products.  Racemic mixture of (1S,2R)-isomer and 
(1R,2S)-isomer are also formed in small amounts. Hydrochloride 
recrystallization isolates  (1S,2S)-isomer and (1R,2R)-isomer from the 
diastereomeric minor racemate [(1R,2S)-isomer and (1S,2R)-isomer] . The 
resolution of the racemate [(1R,2R)-(+)-isomer / (1S,2S)-(–)-isomer] was 
explained by (R)-(–)- or (S)-(+)-mandelic acid66.  
Pharmacodynamics  
Tramadol is available as a racemic mixture ( R- and S-stereoisomers). Its 
volume of distribution is  203 L after parenteral administration and 306 L after 
oral administration approximately. After oral administration,it takes 1 hour to 
analgesic effect to come and peak action in 2-4 hours . Naloxone, opioid 
antagonist can only partially reverse its analgesic effect. It is available as 
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tablets, capsules, including extended release formulations and injections for im 
or iv.70 
Pharmacokinetics 
Tramadol is metabolised in liver via the cytochrome P450 isozyme 
CYP2B6, CYP2D6 and CYP3A4, being O- and N-demethylated to 5 different 
metabolites. O-desmethyltramadol is the more important among five 
metabolites. It is because of its properties like elimination half-life of 9 hours, 
whereas tramadol’s elimination half life is 6 hours and it has two hundred times 
more μ affinity than tramadol . There are studies suggesting requirement of 
30% increase in dose in those with decreased CYP2D6 activity to attain the 
same degree of analgesia as those with normal level of CYP2D6 activity.67,68 
Phase II hepatic metabolism makes the metabolites water-soluble. Water 
soluble metabolites are excreted through kidneys. As tramadol is metabolised 
in liver and excreted by kidney, it is good to reduce its dose in those with 
hepatic and renal impairment.69 
USES 
Tramadol is used mainly for treatment of mild to severe acute and 
pain.69,68   European League Against Rheumatism has recommended tramadol 
for the treatment of fibromyalgia.71 Studies have shown effectiveness of 
tramadol 0.5 mg/kg in suppressing post epidural anesthetic shivering in 
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parturients and concluded that it is as effective as meperidine 0.5 mg/kg28 with 
less sedation. 
Side effects 
Serious side effects may include decreased alertness, increased risk of 
serotonin syndrome, seizures and drug addiction. It should be used with caution 
when combined with drugs that can lower seizure threshold eg: neuroleptic 
agents, mono amino oxidase inhibitors. Common side effects are nausea and 
vomiting. Dose need to be adjusted in liver and renal diseases. It should be 
avoided in patients with suicidal tendency and breast feeding women.72 
Drug interactions 
Tramadol interacts with certain herbs (e.g. passiflora, St. John's wort 
etc.), tricyclic antidepressants, serotonergics, noradrenergic and specific 
serotonergic antidepressants, monoamine oxidase inhibitors, serotonin-
norepinephrine reuptake inhibitors, certain analgesics (fentanyl, oxycodone, 
dextromethorphan and pethidine ),  selective serotonin reuptake inhibitors, 
serotonin antagonist and reuptake inhibitors, certain anxiolytics (such as the 
buspirone and SSRIs), certain antibiotics (isoniazid and linezolid), methylene 
blue, lithium, phenethylamines, amphetamines, phentermine and others.73,70 
Any enzyme inducer or inhibitor will interact with tramadol as it is metabolised 
by cytochrome P450 enzyme. Administration of combinations of amphetamine 
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and tramadol cause epinephrine or norepinephrine receptors toxicity or 
dysfunction.70,74 
  Trekona NA75, et al in 2004, conducted a study in hundred patients on 
therapeutic effect of opioid tramadol hydrochloride in treatment of 
postoperative shivering. They concluded that tramadol 1-2 mg/kg arrested post 
operative shivering in about 98% of patients. 
 De Witte J76, et al in 1997 studied on effects of normal saline and 
tramadol in 3 doses (0.5mg/kg, 1mg/kg and 2mg/kg)  in suppression of post 
operative shivering in 40 patients after general anaesthesia. They found that 
tramadol have weak sedative properties and high safety profile. So it is 
considered as a better option in patients with decreased cardiorespiratory 
reserve. 
 Najafi Anaraki A77, et al in 2012 studied effects of combination of 
pethidine with heavy lignocaine intrathecally on blood loss and haemodynamic 
changes on 77 patients posted for open prostatectomy. They concluded that it 
has minimal effect on hemodynamics intraoperatively but prevent blood loss in 
post operative room. 
 Mohta M78, et al in 2009 studied on comparison of intravenous 
pethidine 0.5 mg/kg with tramadol 1, 2 and 3 mg/kg for prevention of 
postanaesthetic shivering and to find a dose of tramadol that could provide 
analgesic effect and antishivering effect in the postoperative room. The study 
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included 165 patients, randomly allocated to 5 groups of thirty three each. 
Pethidine 0.5 mg/kg, tramadol in doses of 1, 2 and 3 mg/kg, or normal saline 
were administered at the time of suturing. All 3 doses of tramadol were found 
to be effective and comparable to  pethidine in preventing postanaesthetic 
shivering. Among all doses, tramadol at 2 mg/kg had the best combination of 
analgesic and antishivering efficacy without excessive sedation and so seemed 
to be a good option to be given at the time of suturing to provide antishivering 
effect and analgesia without any major adverse effects in the postoperative 
room. 
 Khooshideh M79 et al. in 2009 conducted a study on comparison of 
tramadol and pethidine on duration of analgesia during labour in 160 patients. 
They found that tramadol to have less incidence of maternal side effects short 
duration of  labour analgesia when compared to pethidine,mainly in 2nd stage of 
labour.  
 Tarkkila P3 et al. in 1998 studied on comparison of effects of tramadol 
and pethidine on respiration system on 36 patients. They concluded that 
tramadol 0.6mg/kg does not produce ventilatory depression.   
 Bhatnagar S1 et al. in 2001 conducted a double blind study on 
comparison of effects of tramadol on postoperative shivering with pethidine. 
They did this study on 30 ASA I and II patients. Patients received either 
intravenous pethidine 0.5 mg/kg or tramadol 1 mg/kg. Tramadol ceased 
shivering in 12 patients ,whereas pethidine stopped shivering in only 4 patients. 
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This result was statistically significant also. Recurrence rate in tramadol group 
was zero. So they arrived at a conclusion that iv tramadol 1 mg/kg is more 
effective than pethidine 0.5 mg/kg for treatment of postoperative shivering . 
 Anne Miu Han Chan2 et al. in 1999 studied on control of shivering 
under regional anaesthesia in obstetric patients with tramadol and concluded 
that tramadol is effective in control of intraoperative shivering and no 
demonstrable difference in response rate or side effects between two doses of 
0.5mg/kg and 0.25mg/kg.  
 Van den Berg AA80 et al.  in 1999 did a comparative study on 
analgesic property of nalbuphine(0.3mg/kg) ,tramadol(3 mg/kg) and 
pethidine(1.5 mg/kg) with placebo (saline 0.02ml/kg). This study conducted on 
152 ASA 1 children and young adults posted for adenotonsillectomy. Tramadol 
group required esmolol intra operatively but had analgesia postoperatively 
(P<0.05). Nalbuphine(0.005) and pethidine(P<0.025) group did not require 
esmolol intraoperatively or opioids postoperatively(P<0.005 each). They 
concluded that pethidine 1.5 mg/kg and nalbuphine 0.3 mg/kg is better than 
tramadol 3 mg/kg. Patients in pethidine group had prolonged recovery as 
compared to other two groups. 
 Reda S. Abdelrahman81 did a comparative study on midazolam, 
midazolam plus ketamine, tramadol and tramadol plus ketamine for prevention 
of shivering in 2012. 100 ASA status I and II patients undergoing elective 
orthopedic surgery under lumbar spinal anaesthesia were included in the study. 
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Patients were randomly assigned into 5 groups; group M (n=20) received 
Midazolam 75μg /kg, group C(n=20) received saline as a control, group 
MK(n=20) received Midazolam 37.5μg/kg plus Ketamine 0.25 mg/kg , group 
T(n=20) received Tramadol 0.5mg/kg and group TK(n=20) received Tramadol 
0.25mg/kg plus Ketamine 0.25mg/kg. They found that ketamine when 
combined to any other drug showed more anti-shivering action.So they derived 
at a conclusion that intravenous midazolam plus ketamine or tramadol plus 
ketamine is better than tramadol or midazolam for post spinal shivering. 
 Aditi.A Dhimer82 et al. studied on tramadol for control of shivering 
(comparison with pethidine). Sixty patients from either gender, 20-60 years of 
age, of ASA I, II or III undergoing various surgeries under regional anaesthesia 
were taken for the study. All the patients who experienced shivering were 
randomly divided into Group T and Group P. Group T received Tramadol in a 
dose of 1 mg/kg and Group P received Pethidine in a dose of 1 mg/kg. Result 
of study was: onset of disappearance of shivering was found at around 1 min 
and 3 mins for tramadol, pethidine respectively. Recurrence of shivering after 
50 minutes was found to be 50% in pethidine and 10% in tramadol. 
Complications were more for pethidine compared to tramadol. 
 Serdar Ekemen83 et al. performed a comparison study on  efficacy of 
pethidine and tramadol for postoperative analgesia in children. They concluded 
that pethidine could provide better postop analgesia than tramadol in paediatric 
age group. 
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 I.J Wrench84 et al. did a comparison on pethidine, alfentanil, and 
placebo in the treatment of postoperative shivering. They found alfentanil 250 
mcg had almost same effects as placebo in the treatment of postop shivering. 
Thus they arrived at a conclusion that pethidine with action on kappa receptors 
are more effective for shivering than alfentanil which is a mu receptor agonist .  
 Mahesh T85 et al. did a comparative study on onset, efficacy and 
duration of action of pethidine and tramadol in ceasation of shivering  
intraoperatively. They did this trial on 40 patients of ASA 1 and 2 posted for 
elective surgical procedures under neuraxial block. Group P (n=20) received 
Pethidine 0.5mg/kg IV and group T (n=20) received tramadol 1.0 mg/kg IV.  
Both the drugs were found to be effective in ceasation of shivering. Nineteen 
patients in the Group T stopped  shivering by 5 minutes but  no patients had 
shivering control in Group P (p < 0.0001). This result was found to be 
statistically significant. Both drugs had similar haemodynamic effects. 
Tramadol reduced postanaesthetic shivering at a higher rate than pethidine.  
This study showed that tramadol is more effective for early control of shivering 
and its effect on recurrence of shivering is greater than pethidine. Also, 
Tramadol has less side effects like nausea and vomiting, respiratory depression. 
Tramadol is easily available and cheap drug. Hence concluded tramadol is 
better than pethidine.  
 A Seifi86 et al.did a double blind study on 60 ASA1 or 2 patients who 
developed postop shivering. 30 of them were given with pethidine 0.5mg/kg 
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and remaining 30 were given tramadol 1mg/kg. In this study 16 from thirty 
patients had complete ceasation of shivering with pethidine ( 53.3% ) and 20 
from thirty, improved completely with tramadol (66.66% ).  6.66% of tramadol 
group and 20% of pethidine group had no effect.They concluded that both 
drugs have same effects. This discrepancy could be due to difference in various 
factors like age, duration, temperature which was not considered in this study. 
 R Talakoub87 et al. carried out a double-blind clinical trial on 73 ASA-
I pregnant patients posted for cesarean section under lumbar spinal anesthesia. 
Patients with postop shivering were identified and divided into 2 groups 
receiving tramadol or pethidine to control postop shivering. Group T(tramadol) 
were given 0.5 mg/kg tramadol and group M (meperidine) were given 0.5 
mg/kg meperidine. Both drugs were given as slow iv injection. The response 
rate(cesation of shivering within 15 minutes) was 97.2% and 91.9% for groups 
Tramadol and Meperidine respectively. In conclusion, both pethidine (0.5 
mg/kg) and tramadol (0.5 mg/kg) effectively stopped  post-spinal shivering, but 
tramadol had more adverse effects like nausea, vomiting and somnolence.So 
they recommended further studies on tramadol before considering it as a drug 
of choice for shivering. 
 Sayed Morteza Heidari88et al. conducted a prospective randomized 
double-blind clinical trial.In this study, 80 patients of ASA I and II between 
age group of 15 to 70 years posted for elective surgery under general anesthesia 
were randomly divided to receive oral tramadol 50 mg and placebo. Patients 
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were randomly allocated according to random number table to receive oral 
tramadol 50 mg capsule in the intervention group and placebo with  a 50 mg 
capsule with 50 ml water in the placebo group, 1 hour before surgery by a 
physician who was blinded to the name of drugs. Post anaesthetic shivering 
was seen in 5 patients (12.5%) in the oral tramadol premedication group and 10 
patients (25%) in the placebo group . In this study overall incidence of post 
anaesthetic shivering was not significantly different in the two groups, grades 
of post anaesthetic shivering were significantly lower in the tramadol group. It 
may be due to small sample size and low dose of tramadol.  
 Tahereh P89et al did a double-blind prospective randomized clinical 
trial to study the efficacy of pethidine and buprenorphine for prevention and 
treatment of postanaesthetic shivering. A total of 60 ASA class I-II female 
patients of 18-40 years of age who underwent elective ceasarian section under 
general anesthesia were selected for the study.They are divided randomly to 
two groups of 30 each.One group treated with 0.5 mg/kg pethidine and other 
group treated with 3 μg/kg buprenorphine. They derive at a conclusion that 
buprenorphine is an effective analgesic drug with no hemodynamic 
complication, its antishivering effect even in higher doses is less than 
pethidine.  
 N Manouchehrian90 et al conducted a double blind study on 
comparison of therapeutic effect of pethidine and tramadol for treatment of 
shivering after spinal anaesthesia in elective caesarian section.  They studied 70 
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obstetric patients with ASA class I or II who had shivering following spinal 
anesthesia (SA) . All patients were randomly allocated to one of the two groups 
receiving tramadol 0.5 mg/kg (group T, n = 35), or pethidine 0.5 mg/kg (group 
M, n = 35).  Shivering stopped after 2.57±2.26 and 6.24±4.76 mins in group T 
and group M respectively. In pethidine group, hemodynamic changes before 
and after was found to be statistically significant (p<0.001). Nausea and 
vomiting occurred more frequently in the meperidine group compared to the 
tramadol group (p<0.001). They concluded that tramadol is more effective than 
pethidine in the treatment of postoperative shivering, with less side effects in 
obstetric patients. 
 Javaherforoosh F91 et al. studied effects of tramadol for postoperative 
shivering in elective caesarian section. Ninety patients who underwent cesarean 
section of American Society of Anesthesiologist (ASA) I or II, were randomly 
allocated to one of two groups. Towards the end of operation, 1mg/kg tramadol 
in 20ml normal saline administered to study group and 20ml of normal saline 
to control group was slowly injected intravenously. 39 patients(86.6%)in 
control group developed shivering, while only four patients (8.8%)in study 
group developed shivering. They found tramadol to be safe and effective in 
prevention and treatment of post spinal anaesthesia shivering. This drug had no 
hemodynamic side effect and did not affect arterial oxygen saturation 
percentage and body temperature. 
 Zahedi H92 conducted study on comparison of tramadol and pethidine 
for post anaesthetic shivering in elective cataract surgery.This study was 
Review of Literature  
 
47 
 
conducted on 300 patients. Intravenous tramadol 1 mg/kg or pethidine 0.5 
mg/kg was given for alternate subjects who developed postanesthetic shivering. 
In the tramadol group, shivering terminated within eight minutes after injection 
and had no recurrence of shivering, respiratory depression, reduction in SpO2 
and nausea or vomiting during post operative period. In the pethidine group, 
shivering ceased within 13 minutes after injection, but had recurrence in 10 
patients after 30 minutes. In pethidine group 28 patients had desaturation, 
respiratory depression, nausea and vomiting but none of them needed any 
medication. They concluded that tramadol is superior to pethidine as it induced 
a faster ceasation of postanesthetic shivering and did not have any adverse 
effects on the respiratory system and, recurrence of shivering or nausea and 
vomiting. Easy availability and minimum monitoring requirements are other 
advantages of tramadol.  
 Lim F93 et al. did a study on comparison of tramadol, pethidine and 
dexmedetomidine for the treatment of post neuraxial anaesthesia shivering. 20 
patients were selected for each group. They were divided and treated with 
either iv dexmedetomidine 0.5 μg/kg, pethidine 0.5 mg/kg or tramadol 0.5 
mg/kg. The dexmedetomidine group had highest response rate, and it was 
statistically significant when compared to the tramadol group (p = 0.0012).  
Response rate of  pethidine group  was better than tramadol group but was not 
statistically significant (p = 0.082). There was no statistically significant 
difference in time from the start of treatment to the cessation of shivering and 
efficiency between the three groups. In conclusion, dexmedetomidine 0.5 μg/kg 
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was found to be more effective than tramadol 0.5 mg/kg and pethidine 0.5 
mg/kg, and both tramadol and pethidine have similar efficacy, in the treatment 
of post neuraxial anaesthesia shivering. Significant side effects of 
dexmedetomidine was hypotension and bradycardia.  
 Singh SN94 et al.conducted a randomized clinical trial for comparing 
pethidine and tramadol for prophylaxis of post anaesthetic shivering in patients 
posted for elective abdominal surgery.They conducted study on 120 patients. Iv 
pethidine (0.5mg/kg) or tramadol (1mg/kg) was given to alternate subjects who 
developed post anaestheic shivering. Tramadol stopped shivering within 5 
minutes after administration and had no recurrence of shivering, SPO2 
reduction,  respiratory depression, nausea and vomiting during postop period. 
Pethidine stopped shivering within 8 minutes after administration, but 7 
patients had recurrence after 30 minutes and 6 patients had  SPO2 reduction, 
respiratory depression, and 10 patients had nausea and vomiting but none of 
them required any intervention. So they concluded that tramadol is better 
option than pethidine to control postop shivering with less side effects. 
 Ezike95 et al,did a randomised control study in 80 children between 5 
to 18 years of age to find efficacy of tramadol and pethidine in controlling post 
anaesthetic shivering. The children were randomized to receive 0.4 mg/kg of 
either drug. The mean time for cessation of post anaesthetic shivering 
following treatment with tramadol was 5.57 min , while with pethidine was 
7.42 min (P = 0.04). This difference was significant. 4 (10%) patients in the 
tramadol group and 17 (42.5%) patients in the pethidine group developed 
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significant side effects(P = 0.03) . There was a 10% recurrence of post 
anaesthetic shivering after 45 min in the tramadol-treated group and a 50% 
recurrence with the pethidine-treated group. Rescue treatment with 0.25mg/kg 
of the medication was given in all cases. They came to a conclusion that  
tramadol is recommended for the treatment of post anaesthetic shivering in 
children as it has a faster onset of action,  less recurrence rate, and  less side 
effects when compared with pethidine at same dose.                    
 Hoseinkhan Z96 et al conducted a prospective, randomized, placebo-
controlled, double-blinded, clinical trial on a study population of 72 adults 
scheduled for elective surgery under general anaesthesia in 2003. After 
transferring the patients to the recovery room, shivering was noted and, in 
patients with a shivering score of 1 or more was randomly administered 
intravenous morphine (2.5 mg), pethidine (25 mg), fentanyl (25 μg) or normal 
saline with a volume of 10 ml by a 2 minute injection. A second shivering 
score was recorded 10 minutes later.They conclusion was pethidine and 
fentanyl were significantly more effective than normal saline, but  no 
significant difference between normal saline and morphine groups. Pethidine 
was more effective than other two drugs in shivering control. So they 
interpreted that pethidine was more effective than two other drugs. Fentanyl 
was found to be less effective than pethidine in controlling shivering, whereas 
morphine had no effect on postoperative shivering similar to normal saline. 
 Nasir A97 et al did a study on 90 patients of American Society of 
Anesthesiologist (ASA) grades I and II of either sex, 18-60 years of age posted 
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for elective orthopedic surgery of lower limbs under spinal anaesthesia. They 
were randomly divided into 3 groups. Just after intrathecal bupivacaine 
injection, all patients received prophylactically intravenous drug as either 
normal saline (Group S, n=30) or ketamine 0.5mg/kg (Group K, n =30) or 
tramadol 0.5mg/kg (Group T, no=30) for shivering. The intraoperative 
shivering was found to be significantly less in ketamine group than in the 
normal saline group (p <0.05). 18 patients in normal saline group had grade 2 
shivering and were treated with tramadol.  3 patients in ketamine group had 
grade 2 shivering. 2 patients in tramadol group  had grade 2 shivering. After 30 
min, there were no difference in the grade of shivering between groups 
(p>0.05). No patients required a second dose of tramadol for grade 2 shivering 
within 30 minutes. They concluded that prophylactic use of ketamine had a 
similar efficacy as that of tramadol in preventing post spinal shivering in 
elective lower limb surgery. 
 Tariq MA98 carried out randomized clinical trial in 2012. 200 patients 
of ASA I-II, posted for urologic surgery were selected by card method into 2 
groups of 100 each. All patients were given spinal anaesthesia with 15 mg 
bupivacaine. The patients were allocated to receive ketamine 0.25 mg/kg plus 
midazolam 37.5 μg/kg (Group A) or ketamine 0.5 mg/kg alone (Group B). A 
shivering score  at 5 min intervals was recorded during surgery. After 15 
minutes after spinal anaesthesia, if a grade 3 or 4 shivering developed, then 
prophylaxis considered ineffective and pethidine 25 mg iv given.  The 
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incidences of shivering in groups A and B were 4% and 25% after 15 minutes. 
Group B had significant number of patients with grade 3 or more shivering( 
P=0.0434). So they arrived at a conclusion that prophylactic use of ketamine 
(0.25 mg/kg) plus midazolam (37.5 μg/kg) iv was more effective than iv 
ketamine (0.5 mg/kg) alone in preventing shivering developed during spinal 
anaesthesia. 
 Porwal Sanjay K et al99 did a study on 60 ASA I and II patients. 
Neuraxial anaesthesia was performed with 3.0 ml of 0.5% of Bupivacaine 
heavy in all patients The patients were divided into 2 groups of 30 each to 
receive tramadol 0.5 mg/kg (group T) and ketamine 0.5 mg/kg (group K)  
intravenous after  appearance of shivering. Disappearance and recurrence of 
shivering noted. If recurrence of shivering if occurred then additional dose of 
either ketamine or tramadol 0.5 mg/kg was given in respective group.In their 
study they found that disappearance of shivering was found at 1 minute in 
tramadol group P<0.05 and 3 minutes in ketamine group  <0.05. The complete 
disappearance of shivering took 5 minutes for tramadol group and 8 minutes 
for ketamine group. Recurrence rate of shivering was 10% in T and 20% in K 
group of patients respectively. No complications other than nausea and 
vomiting were noted in the study.In conclusion, tramadol and ketamine were 
found equally efficacious, but tramadol was more potent in controlling 
shivering and its recurrence.  
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 S Atashkhoy100 et al conducted a randomised double blind clinical trial 
in 70 healthy obstetric patients. 35 patients were randomly given intravenous 
tramadol 1mg/kg and 35 patients were given normal saline. They found lower 
incidence of shivering in  patients received tramadol(26.57%) compared to 
patients who received normal saline(65.71%)(p<0.0001). 26 patients who 
received normal saline had postoperative pain whereas only 4 patients of 
tramadol had  pain. Thus they concluded that 1 mg/kg tramadol is effective for 
prevention of shivering after spinal anaesthesia in caesarian section.  
 Philip et al101, did a randomized, double-blind study in 116 ASA I and 
II physical status patients undergoing hip, lower abdominal, lower limb and 
urogenital surgeries. Sixty patients who developed shivering after 
administering epidural anesthesia were divided into 2 groups and received 
either intravenous 25 mg pethidine or 50 mg tramadol. The disappearance, 
recurrence of shivering, hemodynamic and respiratory parameters were 
monitored at regular intervals. Complete disappearance of shivering in majority 
of patients took less than 5 min in tramadol group and 10 min in pethidine 
group that was statistically significant (P < 0.05). Recurrence of shivering was 
more in pethidine group (33%) than tramadol group (14%). Hemodynamic and 
respiratory parameters were comparable in two groups. Adverse effects like 
nausea and vomiting was more in tramadol group (20%) compared to 
pethidine(16%), which was not statistically significant (P > 0.05). They 
concluded that both tramadol and pethidine are equally effective in abolishing 
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shivering during epidural anesthesia, tramadol is faster acting and low 
recurrence rate compared with pethidine. 
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                                                METHODOLOGY 
 The present study was conducted in the department of anaesthesiology 
of Sree Mookambika Institute of Medical Sciences, Kulasekharam, 
Kanyakumari.  The study was started after getting clearance from ethical 
committee of Sree Mookambika Institute of Medical Sciences, Kulasekharam, 
Kanyakumari. The data was collected from 74 patients of both genders of ASA 
1 and 2 between 20-65 years of age.The study was conducted over a period of 
one year (2014-2015). 
Design of study:Randomised controlled trial 
 Sample size:The sample size of this study was 74. Scientific basis of 
sample size used in the study was based on the ratio between recurrence of 
shivering with reference from study of Aditi.A Dhimer, with α error-5%, 
power-95%, sample size on each arm found to be 37 each, using EZR version 
1.1 on R commander version 1.8-4. 
 The study group (n=74) was divided into two groups consisting of 
equal number. 
Group I:This group (n=37) received intravenous tramadol 1mg/kg when they 
developed shivering post operatively. 
Group II:This group (n=37) received intravenous pethidine 0.5mg/kg when 
they developed shivering post operatively. 
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Inclusion criteria:  
1.  Patients giving valid consent. 
2.  Patients under ASA (American Society Of Anaesthesiologist) physical 
status I and II. 
ASA I-Normal healthy patients, ASA II-Patients with mild systemic 
disease without any functional limitation. 
3.  Patients undergoing surgery under spinal anaesthesia. 
4.  Patients of both genders aged between 20 to 65 years. 
Exclusion criteria: 
1. Patients who are not giving consent. 
2. Patients with ASA physical status III or more. 
3. Patients who are allergic to any of these drugs. 
4.  Patients with thyroid disease, obesity, fever and compromised  
            cardiovascular status, seizure disorder. 
5.  Contraindication to spinal anaesthesia like raised intracranial pressure, 
coagulopathy, patient’s refusal etc. 
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Methods 
 The study was conducted on patients of both genders of age group 20-
65 years with American Society of Anaesthesiology physical status I or II 
undergoing surgery under spinal anaesthesia who develop shivering in the post 
operative period upto 2 hours. They were divided into two equal groups. Group 
I- received 1 mg/kg Tramadol and Group II- received 0.5 mg/kg Pethidine. 
           All the patients were visited preoperatively on the night before surgery 
and a detailed history and detailed evaluation was done. All routine 
investigations according to hospital protocol were done. A written informed 
consent obtained if inclusion criteria was met. Standard routine monitors were 
connected to all patients in recovery room and  recorded all parameters. Special 
care was taken to infuse intravenous fluids at room temperature and maintain 
operating room and recovery room temperature at 26 to 30 degree Celsius. 
Spinal anaesthesia was performed with 23 , 25 or 26 G Quincke spinal needle 
in lateral/sitting position at L₂-₃/L₃‐₄  interspace with 0.5% heavy(due to 
addiction of dextrose) bupivacaine in a dose of 1.8 ml-4 ml to get adequate 
block level at T8-10 dermatome in accordance with surgical procedures. 
Patients were closely monitored for occurrence of shivering in post operative 
period. 
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           Shivering intensity was graded on a scale of 0-3;    
 0-  in cases  with no shivering,   
1- Shivering localised in face and  head (mild),                                                                         
2-    visible tremors with involvement of more than one group of muscle 
       (moderate),  
3 gross muscular activity which involves entire body,bed shaking(severe). 
                Patients with shivering of grade 2 or 3 during postoperative period 
were given treatment. From the start of shivering (grade 2 or 3), O₂ 
administered with face mask at 6L/min  and drug as per group allocation were 
administered. Shivering control was said to be achieved when shivering score 
declined to 0 after drug administration, said to be incomplete when scores 
reduced but did not stop the shivering completely and said to be failed if no 
change in shivering scores post treatment.                                                                    
Sedation was assessed on a 4-point scale in which grade                                                            
0-alert,  
1-arouse to voice,                                                                                                                         
2-arouse to tactile stimulation and                                                                                               
4-no awareness. 
             The time taken for cessation of rigors and haemodynamic changes 
were recorded at regular 5 minutes interval up to 15 minutes. Recurrence of 
shivering noted and additional dose of tramadol and pethidine given in 
respective groups. 
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Statistical analysis  
Statistical Package for Social Sciences (SPSS 16.0) used for statistical 
analysis. Unpaired sample t test applied to find the statistical significant 
between the groups. P value less than 0.05 (P<0.05) considered statistically 
significant at 95% confidence interval. The data expressed in number, 
percentage, mean and standard deviation. Data entered in microsoft excel sheet.  
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RESULTS 
 
Table-1: Comparison of demographic data between the groups 
Demographic data Group-I (Tramadol) Group-II (Pethidine) 
Age (years) 
(MEAN±SD) 
44.45±1.21 42.18±1.39 
Gender   
Male 16 (43.24 %) 19 (51.35 %) 
Female 21 (56.76 %) 18 (48.65 %) 
Body weight (Kg) 
(MEAN±SD) 
56.81±8.69 57.21±8.61 
 
The demographic data of age, gender and weight are expressed as 
numbers and percentages. 
In both study groups the age distribution is more or less the same.In group I,16 
males (43.24%) and 21 females (56.76%) were included whereas in group II,19 
males (51.35%) and 18 (48.65%) were included. 
Most of the patients in the study had weight between 40-60 kg. 
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Table-2: Comparison of time of onset, duration and grade of shivering 
between two groups  
Shivering 
parameters 
Group-I (Tramadol) 
(MEAN±SD) 
Group-II (Pethidine)  
(MEAN±SD) 
P value 
Time of onset 17.70±11.40 13.37±8.66 0.07 
Duration of 
shivering 
5.08±4.81 7.11±4.78* 0.03 
Grade of 
shivering 
2.24±0.43 2.21±0.41 0.48 
(*P<0.05 significant compared group-I with group-II) 
Time of onset of shivering post operatively was noted .It cannot be compared 
as this study includes different types of surgeries. 
Duration of shivering signifies the onset of drug action .Group I has lesser 
duration of shivering as compared to group II.That means tramadol ceases 
shivering faster than pethidine.  
Only patients with  2 or 3 grade of shivering are included in the study. 
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Table-3: Distribution of patients according to grade of shivering  
Grade of 
shivering 
Group-I Group-II 
Number Percentage 
(%) 
Number Percentage 
(%) 
0 grade 0 00.00 0 00.00 
1st grade 0 00.00 0 00.00 
2nd grade 28 75.66 29 78.38 
3rd grade  9 24.34 8 21.62 
 
In group I, 28 patients had grade 2 shivering and 9 patients had grade 3 
shivering. In group II, 29 patients had grade 2 shivering and 8 patients had 
grade 3 shivering. 
Table-4: Distribution of patients according to time of onset  
Time of 
onset of 
shivering 
Group-I Group-II 
Number Percentage 
(%) 
Number Percentage 
(%) 
1-10 min 19 51.36 23 62.16 
11-20 min 7 18.92 8 21.63 
21-30 min 7 18.92 5 13.51 
31-40 min 3 08.10 1 02.70 
41-50 min 1 02.70 0  
In group I and II , greater number of patients developed shivering within first 
10 minutes in recovery room. 
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Table-5: Distribution of patients according to duration of shivering 
 
Duration 
of 
shivering 
Group-I Group-II 
Number Percentage 
(%) 
Number Percentage 
(%) 
1-10 min 36 97.30 34 91.89 
11-20 min 0 00.00 2 05.41 
21-30 min 1 02.70 1 02.70 
 
Most of the patients in group I stopped shivering in first 10 minutes compared 
to patients in group II. 
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Table-6: Comparison of heart rate between the groups at different time 
intervals  
Group Heart rate 
before 
shivering 
Mean±SD 
Heart rate  
(0 min) 
Mean±SD 
Heart rate  
(5 min) 
Mean±SD 
Heart rate 
(10 min) 
Mean±SD 
Heart rate 
(15  min) 
Mean±SD 
Group-I 75.48±1.39 76.51±1.39 76.78±1.35 76.67±1.24 76.51±1.19 
Group-II 70.83±7.28 73.54±8.63 75.35±8.45 74.97±8.28 75.16±8.13 
P value  0.07 0.49 0.57 0.27 0.58 
(P>0.05 not significant compared group-I with group-II) 
 
 
There is not much variation in heart rate before shivering, during shivering and 
15 minutes of monitoring in group I. In group II, there is mild increase in heart 
rate after shivering or after administration of drug.    
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Table-11: Comparison of number, percentage of recurrence and grade of 
shivering during recurrence   
Shivering Group-I Group-II P value 
 Number Percentage 
(%) 
Number Percentage 
(%) 
Recurrence  7 18.92 13 35.14* 0.01 
Recurrence 
grade  
     
1st grade 4 10.81 2 05.43* 0.03 
2nd grade 3 08.11 11 29.72* 0.01 
(*P<0.05 significant compared group-I with group-II) 
 
Recurrence rate in group II is more compared to group I. 13 patients in a 
study group II of 37 got recurrence of shivering. Of that 11 patients had grade 2 
shivering and 2 patients had grade 1 shivering.In group 1, only 7 patients had 
recurrence and of which 4 patients had only grade 1 shivering. All these data 
are statistically insignificant. 
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Table-12: Comparison of number and percentage of adverse drug 
reactions between the two groups 
 
Adverse drug 
reaction 
Group-I Group-II 
Number Percentage 
(%) 
Number Percentage 
(%) 
No ADR 28 75.68 29 78.38 
Vomiting 6 16.22 3 08.10 
Sedation  3 08.10 5 13.52 
 
6 patients in group I had vomiting and 3 patients had sedation. In group II, 5 
patients had sedation and 3 patients vomited after giving the drug. 
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                                                 DISCUSSION 
Shivering is an unpleasant condition especially after a surgery. It 
increases intra ocular pressure, intracranial pressure, increase oxygen 
consumption, result in wound pain. The cause of shivering after regional 
anesthesia is not well known, but the probable causes could be decrease in core 
body temperature after sympathetic block; enhanced cutaneous blood flow, 
peripheral vasodilatation; which leads to increased heat loss through skin; rapid 
infusion of cold intravenous fluids; cold temperature of operation room; and  
cold anesthetic drugs stimulating thermosensitive receptors in the spinal cord. 
So shivering should be effectively controlled as fast as possible.  
Many methods have been tried for control of shivering like body 
warmers, using warm iv fluids, blankets etc.Many drugs have been studied for 
their effectiveness for control of shivering like pethidine, nalbuphine, tramadol 
or butorphanol , ketanserin, ondansetron propofol,  granisetron, doxapram, 
clonidine, physostigmine, and nefopam etc. But still an effective drug for 
control of shivering not yet found.  
In our study we could not find any relationship of shivering to age, 
gender, type of surgery, duration of surgery. Most of the patients were 
normothermic , so shivering related to hypothermia is ruled out.  
In this study, we have compared two drugs : pethidine - which was 
considered standard drug for shivering and tramadol – a new synthetic opioid. 
Many causes of shivering has been postulated but still exact cause is unclear.  
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Pethidine is a phenylpiperidine derivative. It has agonist action at κ and 
µ opioid receptors.This should not be used in higher dosage as it can cause 
hemodynamic instability, myocardial depression, seizures due to accumulation 
of its metabolite, nausea , vomiting, sedation and respiratory depression. Total 
daily dose should not exceed 1000mg. 
In this study, group II patients with grade 2 or 3 shivering received 0.5 
mg/kg and we did not observe any serious complications in our patients other 
than nausea and vomiting for 3 patients and sedation for 5 patients. Nausea, 
vomiting of patients could be managed with promethazine or ondansetron.The 
main disadvantage of pethidine noted in this study was their recurrence rate and 
on comparing to tramadol, it took more time to cease shivering. Availability of 
this drug is a problem as it need drug registration. Singh94 et al found that 
patients had respiratory depression, nausea and vomiting and reduction in 
oxygen saturation associated with pethidine 0.5 mg/kg. Zahedi92 et al also had 
same complications with pethidine used in control of shivering in patients 
under general anaesthesia. 
  Tramadol hydrochloride, a μ-opioid receptor agonist , act on central 
mono-aminergic pathways, and cause inhibition of the neuronal uptake of 
serotonin or noradrenaline and encourage hydroxytryptamine  secretion which  
has a major role in regulating the body temperature regulation center.  
Group I patients in our study received tramadol 1 mg/kg when they 
developed grade 2 or 3 shivering. In most of the cases, it could cease shivering 
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within 3 minutes and recurrence rate was also less compared to group II. 
Disadvantage of this drug noted was nausea and vomiting, but it could be 
managed with ondansetron. Tramadol is freely available without drug licence 
and it is cheaper than pethidine.  
Many studies have been conducted to find the ideal drug for shivering. 
But such a drug is under debate. Javaherforoosh F91 et al.studied prophylactic 
effect of 1mg/kg tramadol for caesarian section. Only 8.8 % patients developed 
shivering after receiving tramadol. Heidari88 et al studied effectiveness of oral 
tramadol as premedication. They concluded that it reduced incidence of 
shivering. Dar 97 et al compared tramadol and ketamine for prevention of 
shivering. Bhatnagar1 et al concluded in his study that tramadol 1 mg/kg is 
effective in controlling shivering with less side effects. That is the reason why 
we chose the same dose in our study.  
Manouchehrian N90 et al conducted a double blind study for 
comparison of therapeutic effect of pethidine and tramadol for treatment of 
post spinal anaesthesia shivering in elective caesarian section. As in our study, 
they also found response time of tramadol is less comparatively. In our study, 
there was variation in heart rate in pethidine group before, during and after 
shivering. But they found variation in heart rate, oxygen saturation and 
respiratory rate in pethidine group. As contradiction to our study, they found 
nausea and vomiting more in pethidine group. 
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Mathew103 et al. studied different doses of tramadol and found 96% 
success with 1 mg/kg tramadol and 98 % success with 2 mg/kg. Philip101 et al 
conducted study on tramadol and pethidine for shivering control for patients 
under epidural anaesthesia. They had simlar findings as in our study with 50 
mg tramadol and 25 mg pethidine for all patients irrespective of their weight.  
 Joshi SS102 et al compared tramadol with ondansetron and 
butorphanaol and found patients who received tramadol and butorphanal had 
good postoperative analgesia.But there are many other studies with 
contradictory results. Abdelrahman RS81 compared tramadol plus 
ketamine,midazolam plus ketamine,tramadol and ketamine for prevention of 
shivering and found drugs given in combination were more effective than drugs 
used alone.  Fern L93 et al. compared tramadol, pethidine and dexmedetomidine 
for post operative shivering and found dexmedetomidine associated 
bradycardia and hypotension. 
In this study ,there were no significant variation in heart rate, blood 
pressure, oxygen saturation and axillary temperature. The response rate of 
tramadol and pethidine was 5 minutes and 7 minutes respectively. Recurrence 
in shivering noted in both groups.35 % recurrence with pethidine and 18% 
recurrence with tramadol were observed. 
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CONCLUSION 
 
Intravenous tramadol is more effective than pethidine in controlling post 
spinal anaesthesia shivering. Tramadol has less response rate and recurrence. It 
is cheap as compared to pethidine and freely available without drug licence. 
 
 
 
 
 
 
 
 
 
 
Summary  
 
78 
 
SUMMARY 
This study was done to compare efficacy of intravenous tramadol and 
pethidine in controlling post operative shivering after spinal anaesthesia. The 
study was done on 74 ASA1 or 2 patients in age group of 20 to 65 years. 
Patients developing grade 2 or 3 shivering in recovery room were randomly 
divided into two groups of 37 each. Group I medicated with tramadol 1mg/kg 
and group II with pethidine 0.5 mg/kg intravenously. Patients monitored  for 15 
minutes for response, haemodynamic stability and adverse effects . Recurrence 
of shivering also observed in recovery room. If recurrence of shivering with 
grade 2 or 3 occured, a repeat dose of same drug administered. In most of the 
cases, repeat administration were not required  and shivering subsided its own. 
In our study, intravenous tramadol has less response rate compared to 
pethidine. 35% of patients in group II had recurrence whereas only 18% in 
tramadol group.6 patients of group I  and 3 patients of group II experienced 
nausea and vomiting.It was treated with ondansetron. Sedation was more seen 
in pethidine group. 
In conclusion, intravenous tramadol  is more effective in controlling 
shivering in view of fast onset of action, less recurrence rate, cheap and free 
availability without drug licence. 
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ANNEXURE-I 
 
ANNEXURE - II 
CONSENT FORM 
                                                                PART 1 OF 2     
                    INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Participants, 
               We welcome you and thank you for your keen interest in participation in this 
research project. Before you participate in this study, it is important for you  to 
understand why this research is being carried out. This form will provide you all the 
relevant details of this research. It will explain the nature, the purpose, the benefits, the 
risks, the discomforts, the precautions and the information about how this project will be 
carried out. It is important that you read and understand the contents of the form 
carefully. This form may contain certain scientific terms and hence, if you have any 
doubts or if you want more information, you are free to ask the study personnel or the 
contact person mentioned below before you give your consent and also at any time during 
the entire course of the project. 
1.Name of the Principal Investigator:   Dr. Jisha Roy Babu 
                                                                 PG student-MD Anaesthesia 
                                                Sree Mookambika Institute Of  
                                                Medical Sciences 
2. Name of the guide:                             Dr.A.Thavamani 
3. Name of the Co-Guide:                      Dr.Rommy Geever .T 
4.Institute:                                              Sree Mookambika Institute of  
Medical Sciences 
                                                                  Kulasekharam 
                                                                  Kanyakumari district-629161 
                                                                  Tamil Nadu 
 
 
5. Title of the study: 
          A comparative study on effects of Tramadol and Pethidine for post operative 
shivering of patients under spinal anaesthesia. 
  6.Background information: 
  After surgery under spinal anaesthesia, shivering is seen in some patients. Various drugs 
have been tried for to prevent shivering. In this study,we are comparing the effects of 
intravenous Tramadol and Pethidine for postoperative shivering. 
7.Aims and Objectives: 
    1.To study the effect of tramadol and pethidine on postoperative shivering. 
    2. To compare the efficacy and safety of tramadol and pethidine. 
8.Scientific justification of the study: 
                   Shivering is very unpleasant and stressful for the patient after undergoing a 
intracranial pressure and intraocular pressure,interferes with haemodynamics and 
increase wound pain. Various pharmacological and non-pharmacological methods are 
available for control of shivering. Drugs like Clonidine, Doxapram, Pethidine,Tramadol 
etc have been tried but debate on an ideal antishivering drug still continues. Thus in a 
patient with limited myocardial Oxygen reserve or known coronary artery disease, 
shivering may further compromise myocardial function. Here we are comparing a 
synthetic opioid,Tramadol with Pethidine, standard drug for treatment of shivering in 
quest for more safer and efficacious drug. 
9.Procedure for the study: 
                    Patients developing postoperative shivering are divided into two groups. For 
one group 50 mg Tramadol i.v is given and for another group 0.5 mg/kg Pethidine i.v is 
given. Time taken for the drug effect, recurrence of shivering, haemodynamic changes 
are studied for 2 hours postoperatively. 
10.Expected risks for the participants: 
                    Allergy to drug, respiratory depression, nausea and vomiting may occur. 
 
 
11. Expected benefits of research for the participants: 
                    There may not be any personal benefits, but this study will be beneficial for 
the betterment of  the  health sector.                                                                 
12. Maintenance of Confidentiality: 
                     All data collected for the study will be kept confidentially and would reflect 
on general statistical evaluation only and would not reveal any personal details. 
 
13.Why have I been chosen to be in this study? 
                        You developed post operative shivering after spinal anaesthesia and fulfil 
the criteria of selection. 
14. How many people will be in the study? 74 
15.Agreement of Compensation to the participants(In case of a study related 
injury): 
          Yes 
16. Anticipated prorated payment,if any, to the Participant (s) of the study: 
          Nil 
17. Can  I withdraw from the study at any time during the study period? 
          Yes 
18. If there is any new findings/information, would I be informed? 
          Yes 
19. Expected duration of the Participant’s participation in the study 
           2 hours postoperatively. 
20. Any other pertinent information: 
           No 
 
21. Whom do I contact for further information? 
          Dr. Jisha Roy Babu 
 
 
 
                                                                 
 
 
 
Place: 
                                                                                                Signature of Principal Investigator   
Date: 
                                                 
                                                                                                Signature of the Participant 
 
                                       
 
 
                                 For any study related queries,you are free to contact 
                                   
                                                          Dr. Jisha Roy Babu 
                                              Postgraduate-MD Anaesthesiology 
                                                Department of Anaesthesiology 
                                     Sree Mookambika Institute of Medical Sciences, 
                                                               Kulasekharam  
             
                                                         Mobile no: 9751842875 
                                                  Email ID:jisha.roybabu4@gmail.com 
 
                                                        CONSENT FORM      
                                                              PART 2 0F 2                                                                                    
                                        PARTICIPANTS  CONSENT  FORM 
The details of the study have been explained to me in writing and the details have been 
fully explained to me. I am aware that the results of the study may not directly beneficial 
to me but will help in the advancement of medical sciences. I confirm that I have 
understood the study and had the opportunity to ask questions. I understand that my 
participation in the study is voluntary and that I am free to withdraw at any time, without 
giving any reason, without the medical care that will normally be provided by the 
hospital being affected. I agree not to restrict the use of any data or results that arise from 
this study provided such a use is only for scientific purpose(s). I have been given an 
information sheet giving details of the study. I fully consent to participate in the study 
titled “A comparative study on the effects of intravenous tramadol and pethidine for post 
operative shivering under spinal anaesthesia”. 
 
Serial no/Reference no: 
 
Name of the Participant:                                                                  Address of the 
Participant: 
Contact number of the Participant: 
                                                     Signature /thumb impression of the participant/Legal 
guardian 
Witnesses: 
1. 
2.   
 
 
 
ANNEXURE- III 
                                               CASE RECORD FORM 
  
Name: 
Age     : 
Sex     : 
Weight : 
IP no : 
Surgical diagnosis: 
Proposed surgery: 
American society of Anaesthesiologists class: 
Premedication 
Inj.Ranitidine 
Inj.Metoclopramide 
IV fluids-DNS/RL/NS/D5 
Spinal anaesthesia 
Position: 
Site  : 
Needle type and size: 
Drug: 
Total dose: 
Vasopressors: 
Complications if any: 
                                                                     
     
 
Time Pulse    
Rate 
BP Temperature SpO2 Grades 
of 
shivering
Grades 
of 
sedation 
Recurrence 
of 
shivering
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
 
                                                       ANNEXURE -  IV 
LIST OF ABBREVIATIONS 
5-HT                         :                   5 hydroxytrptamine 
ASA                          :                     American Society of Anaesthesiologists  
CBF               :                Cerebral Blood Flow  
CMRO2              :                Cerebral Metabolic Rate of Oxygen 
CNS               :                   Central nervous system 
CSF               :              Cerebro Spinal Fluid 
CT                               :                  Computed tomography 
CVS                            :                    Cardiovascular system 
DBP                            :                    Diastolic blood pressure 
ECG              :                     Electrocardiogram 
GABA             :                       Gamma amino butyric acid 
GIT                             :                      Gastrointestinal system 
ICP               :         Intra Cranial Pressure 
ICU               :        Intensive Care Unit 
IM                               :     Intramuscular 
IOP               : Intra Ocular Pressure 
IV                              :          Intravenouus 
kg                                :         Kilogram 
MAC               : Monitored Anaesthesia Care 
MAP                          :         Mean Arterial Pressure 
mg                               :         Milligram 
min                              :         Minute 
ml                                :         Millilitre 
MRI                             :         Magnetic resonance imaging                   
NS               : Normal Saline 
PACU                        : Post Anaesthesia Care Unit 
PAS                             :         Post anaesthetic shivering 
PDPH                          :         Post dural puncture headache 
Postop                               :          Postoperative 
RS                               :    Respiratory system 
SBP                             :        Systolic blood pressure 
SD                               :        Standard deviation 
Temp                           :  Temperature 
TNS                            :  Transient neurological symptom 
α                                  :   Alpha 
β                                  :  Beta 
γ                                  :  Gamma 
δ                                  :  Delta 
κ                                  : Kappa 
μ                                  :    Mu 
 
 
 
 
 
 
 
ANNEXURE -V 
 
KEYS TO MASTER CHART 
 
Sl no- Serial number 
IP no- IN patient number 
Wt-   Weight 
TOO- Time of onset of shivering 
G -   Grading of shivering 
DS-   Duration of shivering 
A1-   Heart rate before shivering 
A2-   Heart rate at 0 minutes 
A3-   Heart rate at 5 minutes 
A4-   Heart rate at 10 minutes 
A5-   Heart rate at 15 minutes 
B1-    Systolic blood pressure before shivering 
B2-   Systolic blood pressure at 0 minutes 
B3-    Systolic blood pressure at 5 minutes 
B4-    Systolic blood pressure at 10 minutes 
B5-    Systolic blood pressure at 15 minutes 
C1-   Diastolic blood pressure before shivering 
C2-    Diastolic blood pressure at 0 minutes 
C3-    Diastolic blood pressure at 5 minutes 
C4-    Diastolic blood pressure at 10 minutes 
C5 -   Diastolic blood pressure at 15 minutes 
D1-   Oxygen saturation before shivering 
D2-    Oxygen saturation at 0 minute 
D3-    Oxygen saturation at 5 minutes 
D4-    Oxygen saturation at 10 minutes 
D5-    Oxygen saturation at 15 minutes 
E1-   Temperature before shivering 
E2-    Temperature at 0 minute 
E3-    Temperature at 5 minutes 
E4-    Temperature at 10 minutes 
E5-    Temperature at 15 minutes 
R-   Recurrence of shivering 
R1-   Recurrence shivering grading 
ADR- Adverse drug reaction 
 
 
 
SI IP no Name Age  Sex Wt TOO G DS A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5 E1 E2 E3 E4 E5 R R1 ADR Surgery
1 223604 Princy 23 F 50 30 3 30 70 72 72 71 80 120 120 107 125 110 70 70 84 80 80 100 98 98 98 99 98 98 98.6 99 98.6 No 0 NIL LSCS
2 224553 Thankam 51 F 52 10 3 5 60 64 64 68 68 100 108 108 110 110 65 65 65 70 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 vomiting Hysterectomy
3 224310 Prema 53 F 55 30 2 2 70 70 74 74 78 110 110 115 118 110 70 70 76 76 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Vault repair
4 210384 Radhamani 52 F 53 45 3 3 64 64 64 73 80 130 136 136 109 138 76 76 70 90 78 98 98 98 98 98 98.6 98.6 98.6 99 98.6 No 0 NIL Hysterectomy
5 197017 Seiba Nisha 38 F 65 5 2 1 112 112 114 106 106 130 130 118 120 120 80 80 90 80 80 100 100 100 100 100 98 98 98 98 98.6 Yes 1 NIL URSL
6 191612 Sreeja 34 F 60 10 2 2 99 99 90 82 80 90 90 90 100 100 60 60 60 66 66 100 100 100 100 100 98.6 98.6 98 99 98.6 No 0 NIL Laparotomy
7 186419 Gopinath Nair 60 M 70 35 2 3 62 62 60 55 55 120 120 120 118 118 70 70 70 70 70 100 99 100 99 100 98.6 98.6 98.6 99 98.6 No 0 NIL TURP
8 203691 Athira 18 F 35 5 3 3 60 60 60 58 58 100 100 110 110 110 70 70 70 70 70 100 100 100 100 100 98 98 98 98 98.6 Yes 2 vomiting Appendicectomy
9 204273 Kumaraswamy 60 M 50 10 3 5 72 72 72 70 70 100 100 100 98 100 60 60 66 60 60 100 99 100 100 100 98.6 98.6 98.6 99 98 No 0 NIL Rt hemiarthoplasty
10 205080 Faizal Beegum 52 F 60 5 2 5 80 80 73 77 75 120 120 130 130 130 80 80 70 77 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Rt bimalleolar orif
11 197337 Ramesh 41 M 50 10 2 3 69 69 80 77 81 135 135 136 136 139 72 72 82 82 76 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL L Hernioplasty
12 197822 Yesudhas 56 M 62 30 2 10 70 70 72 70 74 130 130 130 130 134 80 80 80 80 76 100 100 100 100 100 98.6 98.6 98.6 99 98.6 Yes 2 NIL Lt tendon repair
13 183421 Bindhu 33 F 56 10 2 10 74 74 76 76 75 90 90 100 95 100 56 56 70 57 66 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL LSCS
14 194416 Priya 23 F 73 10 2 5 75 75 86 86 80 120 120 130 130 120 80 80 80 80 80 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 vomiting LSCS
15 186417 Jalaja 56 F 50 25 2 2 62 62 55 55 55 120 120 118 118 118 70 70 70 70 70 99 99 99 100 100 98.6 98.6 98 99 98.6 No 0 Sedation Hysterectomy
16 197019 Sumathi 48 F 65 10 2 5 110 112 116 116 110 130 130 117 118 117 80 80 90 90 90 100 100 100 100 100 98.6 98.6 98.6 99 98.6 Yes 1 NIL URSL
17 203556 Elta 52 F 48 15 2 5 100 100 82 82 80 86 86 100 100 102 40 40 66 66 66 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Hysterectomy
18 203960 Mallika 42 F 41 20 2 5 74 74 74 80 80 100 100 100 100 100 60 60 60 60 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Hysterectomy
19 237893 Haripriya 22 F 58 10 2 5 68 69 70 70 70 120 120 130 120 120 80 80 80 80 80 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL LSCS
20 206949 Rasi 55 F 48 20 2 5 90 94 88 89 86 100 108 108 108 106 72 72 72 72 72 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Hysterectomy
21 206986 William 53 M 60 40 2 5 90 94 82 80 80 90 90 102 102 102 60 60 56 56 56 100 100 100 100 100 98.6 98.6 98.6 99 98.6 Yes 2 NIL Rt DHS
22 205872 Kavitha 32 F 45 20 2 10 74 74 89 82 80 100 108 97 100 90 70 70 60 57 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 Yes 1 NIL Fistula in ano
23 206572 Samraj 38 M 60 10 2 2 68 68 70 73 70 140 146 120 112 115 80 80 70 65 72 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Varicocele
24 209374 Manuel 55 M 45 10 2 10 50 53 52 55 53 110 117 122 122 122 60 60 66 60 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 Sedation TURP
25 209740 Freeda 32 F 65 15 2 5 80 80 80 80 79 120 120 120 120 124 80 80 80 80 84 100 100 100 100 100 98.6 98.6 98.6 99 98.6 Yes 1 NIL LSCS
26 218918 Sundaran 60 M 56 20 2 2 88 88 88 86 80 110 116 110 110 110 70 70 70 70 70 100 100 100 100 100 98.6 98.6 98 99 98.6 No 0 Sedation TURBT
27 202038 Rajalekshmi 48 F 64 30 3 3 80 80 80 84 80 130 130 120 120 130 70 70 78 78 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Haemorrhoidectomy
28 205833 Vilasini 58 F 60 10 2 5 70 74 74 74 78 120 120 120 120 120 80 80 80 80 80 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Haemorrhoidectomy
29 209351 Radha 53 F 60 15 2 3 80 80 84 86 86 130 130 130 130 130 90 90 90 90 90 100 100 100 100 100 98.6 98.6 98.6 99 98 No 0 vomiting Haemorrhoidectomy
30 209478 Ajikumar 30 M 73 10 3 5 74 76 76 78 78 120 120 120 120 120 80 80 80 80 80 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Lt hernioplasty
31 209999 Vinu 37 M 60 30 2 5 70 74 74 74 78 120 124 124 124 124 80 80 90 86 84 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Fissurectomy
32 213317 Palas 56 M 56 5 3 3 90 90 94 94 96 130 130 130 130 130 90 90 90 90 94 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 Vomiting Rt hernioplasty
33 213508 Harikumar 39 M 58 10 3 2 60 60 60 68 60 110 110 110 112 110 60 60 66 70 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Rt hernioplasty
34 214220 Rajasekhar 36 M 60 30 2 3 70 74 77 74 77 100 100 100 100 100 60 60 66 66 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Appendicectomy
35 214528 Poomani 48 M 70 40 2 3 70 74 75 70 70 100 100 100 100 100 60 60 64 60 60 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Lt Hernioplasty
36 214822 Joseph Raj 44 M 48 10 2 3 60 60 66 68 69 100 108 108 108 100 70 70 70 70 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 NIL Rt hernioplasty
37 215376 Rajayyan 57 M 61 5 2 5 78 78 78 76 76 110 110 110 110 110 70 70 70 74 70 100 100 100 100 100 98.6 98.6 98.6 99 98.6 No 0 Vomiting Appendicectomy
Si. No IP no Name Age  Sex Wt TOO G DS A1 A2 A3 A4 A5 B1 B2 B3 B4 B5 C1 C2 C3 C4 C5 D1 D2 D3 D4 D5 E1 E2 E3 E4 E5 R R1 ADR Surgery
1 183181 Yanose 65 M 54 10 2 5 80 80 80 80 82 110 118 120 114 140 76 70 74 80 80 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL orrhoidectomy
2 206123 hwanath 60 M 60 10 2 5 70 76 76 73 76 100 106 100 90 90 70 70 70 50 50 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 Sedation TURP
3 204430 Victor 46 M 70 25 2 5 77 80 82 87 82 100 104 118 110 110 80 84 75 74 71 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 1 NIL e amputation
4 223603 Bindhu 38 F 62 25 2 6 60 61 60 66 60 100 99 100 110 100 60 57 60 70 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL sterectomy
5 217341 lappan N 48 M 50 10 3 6 74 76 77 76 68 100 110 96 100 106 70 65 60 70 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL TURP
6 225831 Maheen 56 M 56 15 2 8 70 72 75 65 70 140 150 150 170 150 80 80 90 94 90 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ithotripsy
7 14064251 Sunija 23 F 63 25 2 5 80 87 66 78 74 120 130 100 120 120 90 90 60 80 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL LSCS
8 185484 Wilson 55 M 64 10 2 5 82 80 82 80 80 130 140 140 140 140 90 90 90 90 90 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ernioplasty
9 185291 Vijayan 53 M 60 20 2 10 70 70 74 75 70 110 120 120 120 120 80 80 80 80 80 100 100 100 100 100 98 98 98 98 98 NO 0 NIL orrhoidectomy
10 186348 opakum 42 M 64 5 2 15 60 60 66 66 64 100 110 110 114 110 70 70 70 74 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ernioplasty
11 187648 Nisar 29 M 68 5 2 10 70 72 70 70 70 120 130 120 120 120 90 90 80 80 80 99 99 100 99 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL ernioplasty
12 188102 Mini 20 F 50 5 2 5 66 60 64 68 68 100 110 110 130 110 60 70 70 90 74 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 Vomitingendicectomy
13 188946 Chandrik 46 F 61 5 3 5 70 70 74 76 78 110 120 120 124 124 74 80 80 80 80 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL orrhoidectomy
14 190954 Nagaraj 53 M 68 10 2 15 58 60 68 70 74 120 130 130 130 130 86 90 90 90 90 98 99 99 99 98 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ernioplasty
15 191711 kumaran 56 M 56 10 2 30 70 80 82 82 83 130 134 134 134 134 78 90 90 90 90 99 99 99 99 99 98 98 98.6 98 98.6 YES 2 NIL orrhoidectomy
16 195868 Kamaliya 54 M 70 5 3 10 70 72 74 74 76 120 130 130 130 130 80 90 90 90 90 98 98 98 98 98 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ernioplasty
17 198044 Greesan 35 M 65 5 3 5 80 80 84 80 89 100 110 110 110 114 70 70 70 74 74 99 99 99 99 99 98.6 98.6 98.6 98.6 98.6 YES 1 Vomitingendicectomy
18 197710 Rani 33 F 60 5 2 5 60 66 68 68 70 110 100 100 100 108 66 70 77 70 70 99 99 99 99 99 98 98 98 98.6 98.6 NO 0 NIL enburg stripping
19 200741 hul Ham 49 M 48 10 2 6 66 70 72 74 80 130 140 140 140 140 88 90 90 90 90 99 99 99 99 99 98.6 98.6 98.6 98.6 98.6 NO 0 NIL ernioplasty
20 205080 izal Bega 52 F 50 20 2 10 70 80 82 82 84 120 130 130 130 130 80 80 82 82 82 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL F ankle joint
21 203992 ishnamm 63 F 48 10 2 5 80 86 88 80 80 100 120 120 120 120 80 80 80 80 82 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 Sedation DHS
22 204693 Nelson 50 M 66 10 2 6 70 70 72 72 70 110 110 110 110 110 70 70 70 72 72 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL on band wiring
23 207320 Ammini 60 F 50 15 2 5 66 60 64 64 64 100 100 100 100 100 60 60 60 60 60 98 98 98 98 98 98.6 98.6 98.6 98.6 98.6 NO 0 Sedation DHS
24 212010 Paul Raj 47 M 68 20 3 5 70 80 80 80 84 100 110 110 112 112 77 70 74 70 70 100 99 99 99 99 98 98 98 98 98 NO 0 NIL both bone LL
25 213829 Perinbam 35 F 40 30 2 10 70 78 78 80 80 110 120 120 126 130 68 80 86 86 80 99 99 99 99 99 98.6 98.6 98.6 98.6 98.6 YES 2 NIL t removal ankle
26 216573 har Mee 26 M 58 10 2 5 80 90 92 92 94 110 118 118 128 116 80 78 78 88 80 99 99 99 99 99 98.6 98.6 98.6 98.6 98.6 NO 0 NIL t removal ankle
27 223605 Sheela 45 F 48 15 2 6 70 74 80 76 70 100 108 110 112 110 70 70 70 70 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 Vomitingsterectomy
28 223973 Rekha 29 F 48 30 2 7 78 80 80 80 82 110 118 120 114 140 70 70 74 80 80 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL LSCS
29 224655 Saroja 25 F 43 5 2 8 74 75 76 70 76 100 120 120 120 120 88 80 80 88 88 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL LSCS
30 225182 elen Pap 26 F 50 10 3 5 80 80 80 80 80 110 100 100 100 100 58 60 66 60 60 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 Sedationparotomy
31 225194 anikand 61 M 52 10 3 4 88 90 100 100 90 130 140 140 140 140 88 90 98 98 98 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 Sedation URSL
32 219113 Sudha 23 F 45 5 2 5 60 66 67 62 70 100 100 106 110 110 70 70 70 70 80 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL TVT
33 223445 Omana 55 F 50 15 3 5 70 78 77 76 77 110 120 120 120 120 78 88 89 90 90 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL al fistulectomy
34 224198 Nishamil 21 F 60 20 2 3 60 64 66 68 68 100 100 100 100 100 60 60 70 70 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL LSCS
35 225741 Sudakai 30 M 68 10 2 6 70 70 78 78 70 110 120 128 128 120 80 80 86 86 60 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 YES 2 NIL URSL
36 225929 Arya 25 F 53 5 2 4 66 60 64 60 60 100 110 120 110 110 70 70 80 70 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL LSCS
37 231885 Asha 27 F 71 40 2 3 66 68 70 66 68 120 126 120 118 122 60 67 70 72 70 100 100 100 100 100 98.6 98.6 98.6 98.6 98.6 NO 0 NIL LSCS
